Manis A, Palygin O, Khedr S, Levchenko V, Hodges M, Staruschenko A. Relationship between the renin-angiotensin-aldosterone system and renal Kir5.1 channels. Clin Sci (Lond). 2019;133:2449-2461 pubmed publisher

Zhang B, Zhang X, Xu H, Gao X, Zhang G, Zhang H, et al. Dynamic Variation of RAS on Silicotic Fibrosis Pathogenesis in Rats. Curr Med Sci. 2019;39:551-559 pubmed publisher

Zhang B, Xu H, Zhang Y, Yi X, Zhang G, Zhang X, et al. Targeting the RAS axis alleviates silicotic fibrosis and Ang II-induced myofibroblast differentiation via inhibition of the hedgehog signaling pathway. Toxicol Lett. 2019;: pubmed publisher

Nestor J, Arinuma Y, Huerta T, Kowal C, Nasiri E, Kello N, et al. Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors. J Exp Med. 2018;215:2554-2566 pubmed publisher

Waszkielewicz M, Olesiak Banska J, Comby Zerbino C, Bertorelle F, Dagany X, Bansal A, et al. pH-Induced transformation of ligated Au25 to brighter Au23 nanoclusters. Nanoscale. 2018;10:11335-11341 pubmed publisher

Renström L, Stål P, Song Y, Forsgren S. Bilateral muscle fiber and nerve influences by TNF-alpha in response to unilateral muscle overuse - studies on TNF receptor expressions. BMC Musculoskelet Disord. 2017;18:498 pubmed publisher

El Shaer S, Salaheldin T, Saied N, Abdelazim S. In vivo ameliorative effect of cerium oxide nanoparticles in isoproterenol-induced cardiac toxicity. Exp Toxicol Pathol. 2017;69:435-441 pubmed publisher

Zhou Y, Ihmoda I, Phelps R, Bellamy C, Turner A. Following specific podocyte injury captopril protects against progressive long term renal damage. F1000Res. 2015;4:172 pubmed publisher

Ozawa T, Takayama K, Okamoto R, Negoro R, Sakurai F, Tachibana M, et al. Generation of enterocyte-like cells from human induced pluripotent stem cells for drug absorption and metabolism studies in human small intestine. Sci Rep. 2015;5:16479 pubmed publisher

Devarajan S, Yahiro E, Uehara Y, Habe S, Nishiyama A, Miura S, et al. Depressor effect of chymase inhibitor in mice with high salt-induced moderate hypertension. Am J Physiol Heart Circ Physiol. 2015;309:H1987-96 pubmed publisher

Valachová K, Baňasová M, Topoľská D, Sasinková V, Juránek I, Collins M, et al. Influence of tiopronin, captopril and levamisole therapeutics on the oxidative degradation of hyaluronan. Carbohydr Polym. 2015;134:516-23 pubmed publisher

Wang R, Chen J, Zhang Z, Cen Y. Role of chymase in the local renin-angiotensin system in keloids: inhibition of chymase may be an effective therapeutic approach to treat keloids. Drug Des Devel Ther. 2015;9:4979-88 pubmed publisher

Martin M, Kopaliani I, Jannasch A, Mund C, Todorov V, Henle T, et al. Antihypertensive and cardioprotective effects of the dipeptide isoleucine-tryptophan and whey protein hydrolysate. Acta Physiol (Oxf). 2015;215:167-76 pubmed publisher

Quiñones M, Margalef M, Arola Arnal A, Muguerza B, Miguel M, Aleixandre A. The blood pressure effect and related plasma levels of flavan-3-ols in spontaneously hypertensive rats. Food Funct. 2015;6:3479-89 pubmed publisher

Alberto Silva C, Gilio J, Portaro F, Querobino S, Camargo A. Angiotensin-converting enzyme inhibitors of Bothrops jararaca snake venom affect the structure of mice seminiferous epithelium. J Venom Anim Toxins Incl Trop Dis. 2015;21:27 pubmed publisher

Awad A, You H, Gao T, Gvritishvili A, Cooper T, Tombran Tink J. Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury. PLoS ONE. 2015;10:e0133777 pubmed publisher

Zimmer J, Hawlitschek C, Rabald S, Hagendorff A, Zimmer H, Rassler B. Effects of late-onset and long-term captopril and nifedipine treatment in aged spontaneously hypertensive rats: Echocardiographic studies. Hypertens Res. 2015;38:716-22 pubmed publisher

Jackson J, Cogbill E, Santana Davila R, Eldredge C, Collier W, Gradall A, et al. A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache. PLoS ONE. 2015;10:e0130733 pubmed publisher

Li M, Li Y, Huang X, Lu X. Captopril-polyethyleneimine conjugate modified gold nanoparticles for co-delivery of drug and gene in anti-angiogenesis breast cancer therapy. J Biomater Sci Polym Ed. 2015;26:813-27 pubmed publisher

Santiago R, de Brito T, Dias J, Dias G, da Cruz J, Batista J, et al. Riparin B, a Synthetic Compound Analogue of Riparin, Inhibits the Systemic Inflammatory Response and Oxidative Stress in Mice. Inflammation. 2015;38:2203-15 pubmed publisher

Edward J, Pankey E, Jupiter R, Lasker G, Yoo D, Reddy V, et al. Analysis of erectile responses to bradykinin in the anesthetized rat. Am J Physiol Heart Circ Physiol. 2015;309:H499-511 pubmed publisher

Campeiro J, Neshich I, Sant Anna O, Lopes R, Ianzer D, Assakura M, et al. Identification of snake bradykinin-potentiating peptides (BPPs)-simile sequences in rat brain--Potential BPP-like precursor protein?. Biochem Pharmacol. 2015;96:202-15 pubmed publisher

You H, Gao T, Cooper T, Morris S, Awad A. Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathy. Am J Physiol Renal Physiol. 2015;309:F447-55 pubmed publisher

Sivagnanam S, Yin S, Choi J, Park Y, Woo H, Chun B. Biological Properties of Fucoxanthin in Oil Recovered from Two Brown Seaweeds Using Supercritical CO2 Extraction. Mar Drugs. 2015;13:3422-42 pubmed publisher

Srisawat U, Kongrat S, Muanprasat C, Chatsudthipong V. Losartan and Sodium Nitroprusside Effectively Protect against Renal Impairments after Ischemia and Reperfusion in Rats. Biol Pharm Bull. 2015;38:753-62 pubmed publisher

Kozarski M, Klaus A, Vunduk J, Zizak Z, Niksic M, Jakovljević D, et al. Nutraceutical properties of the methanolic extract of edible mushroom Cantharellus cibarius (Fries): primary mechanisms. Food Funct. 2015;6:1875-86 pubmed publisher

Xing D, Wu Y, Li G, Song S, Liu Y, Liu H, et al. Role of cerebrospinal fluid-contacting nucleus in sodium sensing and sodium appetite. Physiol Behav. 2015;147:291-9 pubmed publisher

Rosei C, Withers S, Belcaid L, De Ciuceis C, Rizzoni D, Heagerty A. Blockade of the renin-angiotensin system in small arteries and anticontractile function of perivascular adipose tissue. J Hypertens. 2015;33:1039-45 pubmed publisher

Broseghini Filho G, Almenara C, Vescovi M, Faria T, Vassallo D, Angeli J, et al. Acute Cadmium Exposure Reduces the Local Angiotensin I Converting Enzyme Activity and Increases the Tissue Metal Content. Biol Trace Elem Res. 2015;166:149-56 pubmed publisher

Loh W, Ling W, Murugan D, Lau Y, Achike F, Vanhoutte P, et al. Des-aspartate angiotensin I (DAA-I) reduces endothelial dysfunction in the aorta of the spontaneously hypertensive rat through inhibition of angiotensin II-induced oxidative stress. Vascul Pharmacol. 2015;71:151-8 pubmed publisher

Doherty K, TALBERT D, Trusk P, Moran D, Shell S, Bacus S. Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types. Toxicol Appl Pharmacol. 2015;285:51-60 pubmed publisher

Ye Y, Gong H, Wang X, Wu J, Wang S, Yuan J, et al. Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice. J Cardiovasc Pharmacol. 2015;65:628-39 pubmed publisher

Guzmán Hernández E, Villalobos Molina R, Sánchez Mendoza M, del Valle Mondragon L, Pastelín Hernández G, Ibarra Barajas M. Early co-expression of cyclooxygenase-2 and renin in the rat kidney cortex contributes to the development of N(G)-nitro-L-arginine methyl ester induced hypertension. Can J Physiol Pharmacol. 2015;93:299-308 pubmed publisher

Silva Filho J, Souza M, Henriques M, Morrot A, Savino W, Caruso Neves C, et al. Renin-angiotensin system contributes to naive T-cell migration in vivo. Arch Biochem Biophys. 2015;573:1-13 pubmed publisher

Wang B, Wang F, Zhang Y, Zhao S, Zhao W, Yan S, et al. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3:263-74 pubmed publisher

Magiera S, Baranowska I. A rapid method for determination of 22 selected drugs in human urine by UHPLC/MS/MS for clinical application. J AOAC Int. 2014;97:1526-37 pubmed

Kleekayai T, Harnedy P, O Keeffe M, Poyarkov A, CunhaNeves A, Suntornsuk W, et al. Extraction of antioxidant and ACE inhibitory peptides from Thai traditional fermented shrimp pastes. Food Chem. 2015;176:441-7 pubmed publisher

Flores Monroy J, Valencia Hernández I, Martínez Aguilar L. Ang (1-7) is a modulator of the vasoconstrictor actions of Ang I and Ang II. J Renin Angiotensin Aldosterone Syst. 2015;16:254-9 pubmed publisher

Chang K, Nayak R, Roy S, Perumbeti A, Wellendorf A, Bezold K, et al. Vasculopathy-associated hyperangiotensinemia mobilizes haematopoietic stem cells/progenitors through endothelial ATâ‚‚R and cytoskeletal dysregulation. Nat Commun. 2015;6:5914 pubmed publisher

Ashby E, Miners J, Kumar S, Walter J, Love S, Kehoe P. Investigation of Aβ phosphorylated at serine 8 (pAβ) in Alzheimer's disease, dementia with Lewy bodies and vascular dementia. Neuropathol Appl Neurobiol. 2015;41:428-44 pubmed publisher

Wang W, Chen W, Yang Y, Liu T, Yang H, Xin Z. New phenolic compounds from Coreopsis tinctoria Nutt. and their antioxidant and angiotensin i-converting enzyme inhibitory activities. J Agric Food Chem. 2015;63:200-7 pubmed

Chang C, Lin J, Ruan S, Lee Y, Wu L, Lin M, et al. Comparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality: a nationwide cohort study. J Hypertens. 2015;33:634-42; discussion 642-3 pubmed publisher

Zhang X, Chen Y, Wei H, Qin Y, Hao Y, Zhu Y, et al. Ultrafine carbon black attenuates the antihypertensive effect of captopril in spontaneously hypertensive rats. Inhal Toxicol. 2014;26:853-60 pubmed publisher

Zhang Y, Luo J, Han C, Xu J, Kong L. Bioassay-guided preparative separation of angiotensin-converting enzyme inhibitory C-flavone glycosides from Desmodium styracifolium by recycling complexation high-speed counter-current chromatography. J Pharm Biomed Anal. 2015;102:276-81 pubmed publisher

Saurí J, Millán D, Suñé Negre J, Colom H, Ticó J, Miñarro M, et al. Quality by Design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets. Int J Pharm. 2014;477:431-41 pubmed publisher

Shahveisi K, Mousavi S, Hosseini M, Rad A, Jalali S, Rajaei Z, et al. The role of local renin-angiotensin system on high glucose-induced cell toxicity, apoptosis and reactive oxygen species production in PC12 cells. Iran J Basic Med Sci. 2014;17:613-21 pubmed

Li W, Sullivan M, Zhang S, Worker C, Xiong Z, Speth R, et al. Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension. Hypertension. 2015;65:352-61 pubmed publisher

Rawendra R, Aisha -, Chen S, Chang C, Shih W, Huang T, et al. Isolation and characterization of a novel angiotensin-converting enzyme-inhibitory tripeptide from enzymatic hydrolysis of soft-shelled turtle (Pelodiscus sinensis) egg white: in vitro, in vivo, and in silico study. J Agric Food Chem. 2014;62:12178-85 pubmed publisher

Hurley S, Zhang Z, Beltz T, Xue B, Johnson A. Sensitization of sodium appetite: evidence for sustained molecular changes in the lamina terminalis. Am J Physiol Regul Integr Comp Physiol. 2014;307:R1405-12 pubmed publisher

Hoyer A, Kempfert J, Pritzwald Stegmann P, Mohr F, Dhein S. Acute hemodynamic effects of angiotensin- converting enzyme inhibition after prolonged cardiac arrest with Bretschneider's solution. Naunyn Schmiedebergs Arch Pharmacol. 2014;387:1221-9 pubmed publisher

Guo T, Lok K, Yu C, Li Z. Lung fibrosis: drug screening and disease biomarker identification with a lung slice culture model and subtracted cDNA Library. Altern Lab Anim. 2014;42:235-43 pubmed

Fabbiano S, Menacho Márquez M, Sevilla M, Albarrán Juárez J, Zheng Y, Offermanns S, et al. Genetic dissection of the vav2-rac1 signaling axis in vascular smooth muscle cells. Mol Cell Biol. 2014;34:4404-19 pubmed publisher

Koyama M, Hattori S, Amano Y, Watanabe M, Nakamura K. Blood pressure-lowering peptides from neo-fermented buckwheat sprouts: a new approach to estimating ACE-inhibitory activity. PLoS ONE. 2014;9:e105802 pubmed publisher

Schmitz V, Almeida L, Svensjo E, Monteiro A, Köhl J, Scharfstein J. C5a and bradykinin receptor cross-talk regulates innate and adaptive immunity in Trypanosoma cruzi infection. J Immunol. 2014;193:3613-23 pubmed publisher

Lankhorst S, Kappers M, van Esch J, Smedts F, Sleijfer S, Mathijssen R, et al. Treatment of hypertension and renal injury induced by the angiogenesis inhibitor sunitinib: preclinical study. Hypertension. 2014;64:1282-9 pubmed publisher

Flores Monroy J, Ferrario C, Valencia Hernández I, Hernández Campos M, Martínez Aguilar L. Comparative effects of a novel angiotensin-converting enzyme inhibitor versus captopril on plasma angiotensins after myocardial infarction. Pharmacology. 2014;94:21-8 pubmed publisher

Xie C, Kim J, Ha J, Choung S, Choi Y. Angiotensin I-converting enzyme inhibitor derived from cross-linked oyster protein. Biomed Res Int. 2014;2014:379234 pubmed publisher

Kovarik J, Antlanger M, Domenig O, Kaltenecker C, Hecking M, Haidinger M, et al. Molecular regulation of the renin-angiotensin system in haemodialysis patients. Nephrol Dial Transplant. 2015;30:115-23 pubmed publisher

Mattes W, Davis K, Fabian E, Greenhaw J, Herold M, Looser R, et al. Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma. Toxicol Lett. 2014;230:467-78 pubmed publisher

Kuo C, Balakrishnan P, Hsein Y, Wu V, Chueh S, Chen Y, et al. The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old. J Renin Angiotensin Aldosterone Syst. 2015;16:587-98 pubmed publisher

Moulder J, Cohen E, Fish B. Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors. Int J Radiat Biol. 2014;90:762-8 pubmed publisher

Gupta A, Fujita W, Gomes I, Bobeck E, Devi L. Endothelin-converting enzyme 2 differentially regulates opioid receptor activity. Br J Pharmacol. 2015;172:704-19 pubmed publisher

Jochemsen H, Teunissen C, Ashby E, van der Flier W, Jones R, Geerlings M, et al. The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease. Alzheimers Res Ther. 2014;6:27 pubmed publisher

Ackerman Z, Skarzinski G, Grozovski M, Oron Herman M, Sela B. Effects of antihypertensive and triglyceride-lowering agents on hepatic copper concentrations in rats with fatty liver disease. Basic Clin Pharmacol Toxicol. 2014;115:545-51 pubmed publisher

Xa L, Lacombe M, Mercure C, Lazure C, Reudelhuber T. General lysosomal hydrolysis can process prorenin accurately. Am J Physiol Regul Integr Comp Physiol. 2014;307:R505-13 pubmed publisher

Guevara Lora I, Stalinska K, Augustynek B, Labedz Maslowska A. Influence of kinin peptides on monocyte-endothelial cell adhesion. J Cell Biochem. 2014;115:1985-95 pubmed publisher

Mahmood J, Jelveh S, Zaidi A, Doctrow S, Medhora M, Hill R. Targeting the Renin-angiotensin system combined with an antioxidant is highly effective in mitigating radiation-induced lung damage. Int J Radiat Oncol Biol Phys. 2014;89:722-8 pubmed publisher

Philippe C, Haeusler D, Fuchshuber F, Spreitzer H, Viernstein H, Hacker M, et al. Comparative autoradiographic in vitro investigation of melanin concentrating hormone receptor 1 ligands in the central nervous system. Eur J Pharmacol. 2014;735:177-83 pubmed publisher

Song Y, Stål P, Yu J, Lorentzon R, Backman C, Forsgren S. Inhibitors of endopeptidase and angiotensin-converting enzyme lead to an amplification of the morphological changes and an upregulation of the substance P system in a muscle overuse model. BMC Musculoskelet Disord. 2014;15:126 pubmed publisher

Viana Tejedor A, Nunez Gil I. Images in clinical medicine. Isolated uvular angioedema. N Engl J Med. 2014;370:e24 pubmed publisher

Abdel Wahab B, Metwally M, El khawanki M, Hashim A. Protective effect of captopril against clozapine-induced myocarditis in rats: role of oxidative stress, proinflammatory cytokines and DNA damage. Chem Biol Interact. 2014;216:43-52 pubmed publisher

Miners S, Moulding H, de Silva R, Love S. Reduced vascular endothelial growth factor and capillary density in the occipital cortex in dementia with Lewy bodies. Brain Pathol. 2014;24:334-43 pubmed publisher

Bridle K, Sobbe A, de Guzman C, Santrampurwala N, Jaskowski L, Clouston A, et al. Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2?/? mice. Liver Int. 2015;35:1451-63 pubmed publisher

Li T, Zhou R, Yao Y, Yang Q, Zhou C, Wu W, et al. Angiotensin-converting enzyme inhibitor captopril reverses the adverse cardiovascular effects of polymerized hemoglobin. Antioxid Redox Signal. 2014;21:2095-108 pubmed publisher

Casas M, Alvarez J, Lucero M. Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients. Pharm Dev Technol. 2015;20:271-8 pubmed publisher

Dizdarevic L, Biswas D, Uddin M, Jørgenesen A, Falch E, Bastani N, et al. Inhibitory effects of kiwifruit extract on human platelet aggregation and plasma angiotensin-converting enzyme activity. Platelets. 2014;25:567-75 pubmed publisher

Nevelsteen I, Van den Bergh A, Van der Mieren G, Vanderper A, Mubagwa K, Bult H, et al. NO-dependent endothelial dysfunction in type II diabetes is aggravated by dyslipidemia and hypertension, but can be restored by angiotensin-converting enzyme inhibition and weight loss. J Vasc Res. 2013;50:486-97 pubmed publisher

Tomaschitz A, Pilz S. Interplay between sodium and calcium regulatory hormones: a clinically relevant research field. Hypertension. 2014;63:212-4 pubmed publisher

Brown J, Williams J, Luther J, Garg R, Garza A, Pojoga L, et al. Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone. Hypertension. 2014;63:273-80 pubmed publisher

Sonsalla P, Coleman C, Wong L, Harris S, Richardson J, Gadad B, et al. The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism. Exp Neurol. 2013;250:376-83 pubmed publisher

Zidane F, Zeder Lutz G, Altschuh D, Girardet J, Miclo L, Corbier C, et al. Surface plasmon resonance analysis of the binding mechanism of pharmacological and peptidic inhibitors to human somatic angiotensin I-converting enzyme. Biochemistry. 2013;52:8722-31 pubmed publisher

Brouwers S, Smolders I, Massie A, Dupont A. Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo. Hypertension. 2013;62:920-6 pubmed publisher

Mueller C, Burggren W, Crossley D. ANG II and baroreflex control of heart rate in embryonic chickens (Gallus gallus domesticus). Am J Physiol Regul Integr Comp Physiol. 2013;305:R855-63 pubmed publisher

Ruksin V, Grishin O, Chiritso M. [The efficacy of antihypertension drugs and their combinations in the non-treated hypertension]. Med Tr Prom Ekol. 2013;:7-11 pubmed

Arsenault M, Zendaoui A, Roussel E, Drolet M, Dhahri W, Grenier A, et al. Angiotensin II-converting enzyme inhibition improves survival, ventricular remodeling, and myocardial energetics in experimental aortic regurgitation. Circ Heart Fail. 2013;6:1021-8 pubmed publisher

Vollmer C, Schwartges I, Behmke R, Bauer I, Picker O. Hypercapnia counteracts captopril-induced depression of gastric mucosal oxygenation. J Endocrinol. 2013;218:245-53 pubmed publisher

Huang Z, Bai S, Chen L, Wang J, Ding B. [Effect of puerarin combined with felodipine on mRNA and protein expression of apelin and APJ in renovascular hypertensive rat]. Zhongguo Zhong Yao Za Zhi. 2013;38:381-5 pubmed

Kerimoglu O, Keskin E, Dortunc B, Anah S. Matrix type transdermal therapeutic system containing captopril: formulation optimization, in vitro and ex vivo characterization. Acta Pol Pharm. 2013;70:291-300 pubmed

Borghi C, Cosentino E, Rinaldi E, Cicero A. Effect of zofenopril and ramipril on cardiovascular mortality in patients with chronic heart failure. Am J Cardiol. 2013;112:90-3 pubmed publisher

Persu A, Lambert M, Deinum J, Cossu M, de Visscher N, Irenge L, et al. A novel splice-site mutation in angiotensin I-converting enzyme (ACE) gene, c.3691+1G>A (IVS25+1G>A), causes a dramatic increase in circulating ACE through deletion of the transmembrane anchor. PLoS ONE. 2013;8:e59537 pubmed publisher

Sasongko T, Nagalla S, Ballas S. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. Cochrane Database Syst Rev. 2013;:CD009191 pubmed publisher

Popa C, van Riel P. The use of captopril in rheumatoid arthritis: combining treatment targets!. Can J Cardiol. 2013;29:639.e13 pubmed publisher

Gragasin F, Bourque S, Davidge S. Propofol increases vascular relaxation in aging rats chronically treated with the angiotensin-converting enzyme inhibitor captopril. Anesth Analg. 2013;116:775-83 pubmed publisher

Kapungu G, Rukweza G, Tran T, Mbiya W, Adigun R, Ndungu P, et al. Oxyhalogen-sulfur chemistry: kinetics and mechanism of oxidation of captopril by acidified bromate and aqueous bromine. J Phys Chem A. 2013;117:2704-17 pubmed publisher

Roysommuti S, Thaeomor A, Khimsuksri S, Lerdweeraphon W, Wyss J. Perinatal taurine imbalance alters the interplay of renin-angiotensin system and estrogen on glucose-insulin regulation in adult female rats. Adv Exp Med Biol. 2013;776:67-80 pubmed publisher

Day R, Davis T, Barshishat Kupper M, McCart E, Tipton A, Landauer M. Enhanced hematopoietic protection from radiation by the combination of genistein and captopril. Int Immunopharmacol. 2013;15:348-56 pubmed publisher

Sun Y, Zhang Z, Zhang X. Determination of captopril by high-performance liquid chromatography with direct electrogenerated chemiluminescence. Spectrochim Acta A Mol Biomol Spectrosc. 2013;105:171-5 pubmed publisher

Fouad A, Al Mulhim A, Jresat I, Morsy M. Protective effects of captopril in diabetic rats exposed to ischemia/reperfusion renal injury. J Pharm Pharmacol. 2013;65:243-52 pubmed publisher

Bild W, Hritcu L, Stefanescu C, Ciobica A. Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 2013;43:79-88 pubmed publisher

Arnold A, Okamoto L, Gamboa A, Shibao C, Raj S, Robertson D, et al. Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension. 2013;61:701-6 pubmed publisher

Asnar D, Roncari C, De Luca L, de Paula P, Colombari D, Menani J. Involvement of central cholinergic mechanisms on sodium intake induced by gabaergic activation of the lateral parabrachial nucleus. Neurosci Lett. 2013;534:188-92 pubmed publisher

Karakilic E, Buyukcam F, Kocalar G, Gedik S, Atalar E. Same effect of sublingual and oral captopril in hypertensive crisis. Eur Rev Med Pharmacol Sci. 2012;16:1642-5 pubmed

Pabari R, McDermott C, Barlow J, Ramtoola Z. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation. Clin Ther. 2012;34:2221-9 pubmed publisher

Zhao W, Yu J, Su Q, Liang J, Zhao L, Zhang Y, et al. Antihypertensive effects of extract from Picrasma quassiodes (D. Don) Benn. in spontaneously hypertensive rats. J Ethnopharmacol. 2013;145:187-92 pubmed publisher

Lee D, Maunsbach A, Riquier Brison A, Nguyen M, Fenton R, Bachmann S, et al. Effects of ACE inhibition and ANG II stimulation on renal Na-Cl cotransporter distribution, phosphorylation, and membrane complex properties. Am J Physiol Cell Physiol. 2013;304:C147-63 pubmed publisher

Koh S, Ager E, Malcontenti Wilson C, Muralidharan V, Christophi C. Blockade of the renin-angiotensin system improves the early stages of liver regeneration and liver function. J Surg Res. 2013;179:66-71 pubmed publisher

Lombardi C, Castrini A, Metra M, Carubelli V, Lazzarini V, Inama L, et al. [Efficacy of ACE-inhibitors in patients with recent myocardial infarction. Studies with zofenopril]. G Ital Cardiol (Rome). 2012;13:55S-58S pubmed publisher

Kurbanoglu S, Gumustas M, Ozkan S. Simultaneous estimation and validation of some binary mixtures of antihypertensive drugs by RP-LC methods using two new generation silica columns. J Pharm Biomed Anal. 2013;72:198-201 pubmed publisher

Lin P, Hsieh Y, Kuo W, Lin C, Tsai F, Tsai C, et al. Inhibition of cardiac hypertrophy by probiotic-fermented purple sweet potato yogurt in spontaneously hypertensive rat hearts. Int J Mol Med. 2012;30:1365-75 pubmed publisher

Zhang H, Lou S, Williams G, Branford White C, Nie H, Quan J, et al. A systematic study of captopril-loaded polyester fiber mats prepared by electrospinning. Int J Pharm. 2012;439:100-8 pubmed publisher

Mamenko M, Zaika O, Doris P, Pochynyuk O. Salt-dependent inhibition of epithelial Na+ channel-mediated sodium reabsorption in the aldosterone-sensitive distal nephron by bradykinin. Hypertension. 2012;60:1234-41 pubmed publisher

Borghi C, Bacchelli S, Degli Esposti D. Long-term clinical experience with zofenopril. Expert Rev Cardiovasc Ther. 2012;10:973-82 pubmed publisher

Castro Moreno P, Pardo J, Hernández Muñoz R, Lopez Guerrero J, del Valle Mondragon L, Pastelín Hernández G, et al. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR. Auton Autacoid Pharmacol. 2012;32:61-9 pubmed publisher

Geoghegan P, Sexton D, Giblin L, O REGAN A. Taught a lesson by taut skin. BMJ. 2012;345:e5971 pubmed publisher

Pan J, Xue W, Chen Q, Chen Y, Chen H, Huang Y. Antifibrotic role of captopril after ureteral injury. Urol Int. 2012;89:418-24 pubmed publisher

da Costa Rebelo R, Schreckenberg R, Schluter K. Adverse cardiac remodelling in spontaneously hypertensive rats: acceleration by high aerobic exercise intensity. J Physiol. 2012;590:5389-400 pubmed publisher

Mansour F, Danielson N. Separation methods for captopril in pharmaceuticals and biological fluids. J Sep Sci. 2012;35:1213-26 pubmed publisher

Kast R, Halatsch M. Matrix metalloproteinase-2 and -9 in glioblastoma: a trio of old drugs-captopril, disulfiram and nelfinavir-are inhibitors with potential as adjunctive treatments in glioblastoma. Arch Med Res. 2012;43:243-7 pubmed publisher

Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS Comput Biol. 2011;7:e1002310 pubmed publisher

Faridoon -, Hussein W, Vella P, Islam N, Ollis D, Schenk G, et al. 3-mercapto-1,2,4-triazoles and N-acylated thiosemicarbazides as metallo-?-lactamase inhibitors. Bioorg Med Chem Lett. 2012;22:380-6 pubmed publisher

Camargo A, Ianzer D, Guerreiro J, Serrano S. Bradykinin-potentiating peptides: beyond captopril. Toxicon. 2012;59:516-23 pubmed publisher

Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W. FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today. 2011;16:697-703 pubmed publisher

Uda N, Creus M. Selectivity of Inhibition of N-Succinyl-l,l-Diaminopimelic Acid Desuccinylase in Bacteria: The product of dapE-gene Is Not the Target of l-Captopril Antimicrobial Activity. Bioinorg Chem Appl. 2011;2011:306465 pubmed publisher

Martino T, Tata N, Simpson J, Vanderlaan R, Dawood F, Kabir M, et al. The primary benefits of angiotensin-converting enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophy. J Am Coll Cardiol. 2011;57:2020-8 pubmed publisher

Vella P, Hussein W, Leung E, Clayton D, Ollis D, Mitic N, et al. The identification of new metallo-β-lactamase inhibitor leads from fragment-based screening. Bioorg Med Chem Lett. 2011;21:3282-5 pubmed publisher

Talevi A, Goodarzi M, Ortiz E, Duchowicz P, Bellera C, Pesce G, et al. Prediction of drug intestinal absorption by new linear and non-linear QSPR. Eur J Med Chem. 2011;46:218-28 pubmed publisher

Ekins S, Williams A, Xu J. A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug Metab Dispos. 2010;38:2302-8 pubmed publisher

Abrego V, Martínez Pérez B, Torres L, Angeles E, Martínez L, Marroquín Pascual J, et al. Antihypertensive and antiarrhythmic properties of a para-hydroxy[bis(ortho-morpholinylmethyl)]phenyl-1,4-DHP compound: comparison with other compounds of the same kind and relationship with logP values. Eur J Med Chem. 2010;45:4622-30 pubmed publisher

Greene N, Fisk L, Naven R, Note R, Patel M, Pelletier D. Developing structure-activity relationships for the prediction of hepatotoxicity. Chem Res Toxicol. 2010;23:1215-22 pubmed publisher

Navarrete Vazquez G, Hidalgo Figueroa S, Torres Piedra M, Vergara Galicia J, Rivera Leyva J, Estrada Soto S, et al. Synthesis, vasorelaxant activity and antihypertensive effect of benzo[d]imidazole derivatives. Bioorg Med Chem. 2010;18:3985-91 pubmed publisher

Giacomini K, Huang S, Tweedie D, Benet L, Brouwer K, Chu X, et al. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9:215-36 pubmed publisher

Prado Prado F, Garcia Mera X, González Díaz H. Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorg Med Chem. 2010;18:2225-2231 pubmed publisher

Varma M, Obach R, Rotter C, Miller H, Chang G, Steyn S, et al. Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. J Med Chem. 2010;53:1098-108 pubmed publisher

Uehara T, Ono A, Maruyama T, Kato I, Yamada H, Ohno Y, et al. The Japanese toxicogenomics project: application of toxicogenomics. Mol Nutr Food Res. 2010;54:218-27 pubmed publisher

Guerra A, Campillo N, Paez J. Neural computational prediction of oral drug absorption based on CODES 2D descriptors. Eur J Med Chem. 2010;45:930-40 pubmed publisher

Fourches D, Barnes J, Day N, Bradley P, Reed J, Tropsha A. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol. 2010;23:171-83 pubmed publisher

Gillner D, Armoush N, Holz R, Becker D. Inhibitors of bacterial N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) and demonstration of in vitro antimicrobial activity. Bioorg Med Chem Lett. 2009;19:6350-2 pubmed publisher

Li G, Liu Z. Captopril and 6-mercaptopurine: whose SH possesses higher antioxidant ability?. Eur J Med Chem. 2009;44:4841-7 pubmed publisher

Olimpieri F, Tambaro S, Fustero S, Lazzari P, Sánchez Roselló M, Pani L, et al. Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors. Bioorg Med Chem Lett. 2009;19:4715-9 pubmed publisher

Varma M, Feng B, Obach R, Troutman M, Chupka J, Miller H, et al. Physicochemical determinants of human renal clearance. J Med Chem. 2009;52:4844-52 pubmed publisher

Ismail M, Nabil Aboul Enein M, Abouzid K, Abou El Ella D, Ismail N. ACE inhibitors hypothesis generation for selective design, synthesis and biological evaluation of 3-mercapto-2-methyl-propanoyl-pyrrolidine-3-imine derivatives as antihypertensive agents. Bioorg Med Chem. 2009;17:3739-46 pubmed publisher

Liu J, Ren H, Xu J, Bai R, Yan Q, Huang W, et al. Total synthesis and antihypertensive activity of (+/-)7,8-dihydroxy-3-methyl-isochromanone-4. Bioorg Med Chem Lett. 2009;19:1822-4 pubmed publisher

Attoub S, Gaben A, Al Salam S, Al Sultan M, John A, Nicholls M, et al. Captopril as a potential inhibitor of lung tumor growth and metastasis. Ann N Y Acad Sci. 2008;1138:65-72 pubmed publisher

Santana L, González Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, et al. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem. 2008;51:6740-51 pubmed publisher

Ahlin G, Karlsson J, Pedersen J, Gustavsson L, Larsson R, Matsson P, et al. Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. J Med Chem. 2008;51:5932-42 pubmed publisher

Enomoto H, Morikawa Y, Miyake Y, Tsuji F, Mizuchi M, Suhara H, et al. Synthesis and biological evaluation of N-mercaptoacylproline and N-mercaptoacylthiazolidine-4-carboxylic acid derivatives as leukotriene A4 hydrolase inhibitors. Bioorg Med Chem Lett. 2008;18:4529-32 pubmed publisher

Grice C, Tays K, Savall B, Wei J, Butler C, Axe F, et al. Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity. J Med Chem. 2008;51:4150-69 pubmed publisher

Pedersen J, Matsson P, Bergström C, Norinder U, Hoogstraate J, Artursson P. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). J Med Chem. 2008;51:3275-87 pubmed publisher

Obach R, Lombardo F, Waters N. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos. 2008;36:1385-405 pubmed publisher

Ntai I, Bachmann B. Identification of ACE pharmacophore in the phosphonopeptide metabolite K-26. Bioorg Med Chem Lett. 2008;18:3068-71 pubmed

Velázquez A, Martinez L, Abrego V, Balboa M, Torres L, Camacho B, et al. Synthesis and antihypertensive effects of new methylthiomorpholinphenol derivatives. Eur J Med Chem. 2008;43:486-500 pubmed

Giliarevskiĭ S. [Three lives of captopril in the era of evidence based medicine]. Kardiologiia. 2007;47:82-90 pubmed

Diamandis P, Wildenhain J, Clarke I, Sacher A, Graham J, Bellows D, et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 2007;3:268-73 pubmed

Tzakos A, Naqvi N, Comporozos K, Pierattelli R, Theodorou V, Husain A, et al. The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme. Bioorg Med Chem Lett. 2006;16:5084-7 pubmed

Breschi M, Calderone V, Digiacomo M, Macchia M, Martelli A, Martinotti E, et al. New NO-releasing pharmacodynamic hybrids of losartan and its active metabolite: design, synthesis, and biopharmacological properties. J Med Chem. 2006;49:2628-39 pubmed

Vasiuk I. [Assessment of natriuretic peptides levels in the study of efficacy of perindopril and captopril in myocardial infarction with systolic dysfunction]. Ter Arkh. 2005;77:89-93 pubmed

Morphy R, Rankovic Z. Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem. 2005;48:6523-43 pubmed

Jolivette L, Ward K. Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure. J Pharm Sci. 2005;94:1467-83 pubmed

Nemec K, Schubert Zsilavecz M. [From teprotide to captopril. Rational design of ACE inhibitors]. Pharm Unserer Zeit. 2003;32:11-6 pubmed

Racine M, Douville P, Lebel M. Functional tests for primary aldosteronism: value of captopril suppression. Curr Hypertens Rep. 2002;4:245-9 pubmed

Schattner A, Kozak N, Friedman J. Captopril-induced jaundice: report of 2 cases and a review of 13 additional reports in the literature. Am J Med Sci. 2001;322:236-40 pubmed

Shou I, Fukui M, Tomino Y. Efficacy of ACE inhibitor (captopril) on glomerular antioxidant enzyme activity and hypertension in diabetic hypertensive rats. Contrib Nephrol. 2001;:74-8 pubmed

Peco M. [Converting enzyme inhibitors in the diagnosis of secondary arterial hypertension --focus on the captopril test]. Rev Port Cardiol. 2000;19 Suppl 2:II35-41 pubmed

Nur A, Zhang J. Recent progress in sustained/controlled oral delivery of captopril: an overview. Int J Pharm. 2000;194:139-46 pubmed

Fournier A, Pruna A, Esper N, Makdassi R, Oprisiu R, Westeel P, et al. Captopril prevention project--what shall we do about captopril and the risk of stroke?. Nephrol Dial Transplant. 2000;15:2-5 pubmed

Tondeur M. [Overall and separate clearance--renography with and without captopril]. Rev Med Brux. 1999;20:A352-5 pubmed

Hansson L. Recent intervention trials in hypertension initiated in Sweden--HOT, CAPPP and others. Hypertension Optimal Treatment Study. Captopril Prevention Project. Clin Exp Hypertens. 1999;21:507-15 pubmed

Ogilvie R, Zborowska Sluis D. Captopril and angiotensin II receptor antagonist therapy in a pacing model of heart failure. Can J Cardiol. 1998;14:1025-33 pubmed

Friedman I, Rudikoff D, Phelps R, Sapadin A. Captopril-triggered linear IgA bullous dermatosis. Int J Dermatol. 1998;37:608-12 pubmed

Sadeck L, Fernandes M, Silva S, Trindade A, Chia C, Ramos J, et al. [Captopril use in pregnancy and its effects on the fetus and the newborn: case report]. Rev Hosp Clin Fac Med Sao Paulo. 1997;52:328-32 pubmed

Cserhalmi L. [Effect of combined captopril-spironolactone therapy of cardiac insufficiency on kidney function and serum electrolyte values]. Orv Hetil. 1998;139:63-6 pubmed

Kekes E. [Captopril in the treatment of heart failure]. Acta Pharm Hung. 1997;67:155-63 pubmed